Annual ROE
-37.96%
+5.01%+11.66%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual return on equity is -37.96%, with the most recent change of +5.01% (+11.66%) on December 31, 2023.
- During the last 3 years, DMAC annual ROE has risen by +9.29% (+19.66%).
- DMAC annual ROE is now -112.05% below its all-time high of 314.90%, reached on December 31, 2014.
Performance
DMAC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-43.68%
-5.12%-13.28%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly return on equity is -43.68%, with the most recent change of -5.12% (-13.28%) on September 30, 2024.
- Over the past year, DMAC quarterly ROE has dropped by -2.42% (-5.87%).
- DMAC quarterly ROE is now -105.70% below its all-time high of 766.51%, reached on December 31, 2014.
Performance
DMAC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DMAC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.7% | -5.9% |
| 3 y3 years | +19.7% | +12.5% |
| 5 y5 years | +41.0% | +12.5% |
DMAC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.0% | +11.7% | -36.5% | +6.9% |
| 5 y | 5-year | -23.0% | +72.8% | -36.5% | +56.0% |
| alltime | all time | -112.0% | +91.5% | -105.7% | +98.6% |
DiaMedica Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -43.68%(+13.3%) |
| Jun 2024 | - | -38.56%(+6.5%) |
| Mar 2024 | - | -36.21%(-9.6%) |
| Dec 2023 | -37.96%(-11.7%) | -40.07%(-2.9%) |
| Sep 2023 | - | -41.26%(-4.3%) |
| Jun 2023 | - | -43.10%(-8.1%) |
| Mar 2023 | - | -46.91%(+24.7%) |
| Dec 2022 | -42.97%(+39.2%) | -37.63%(+12.6%) |
| Sep 2022 | - | -33.43%(+4.5%) |
| Jun 2022 | - | -32.00%(-9.7%) |
| Mar 2022 | - | -35.43%(-12.3%) |
| Dec 2021 | -30.87%(-34.7%) | -40.42%(-19.1%) |
| Sep 2021 | - | -49.94%(-13.3%) |
| Jun 2021 | - | -57.60%(-3.7%) |
| Mar 2021 | - | -59.83%(-2.2%) |
| Dec 2020 | -47.25%(-66.2%) | -61.18%(-10.3%) |
| Sep 2020 | - | -68.24%(-27.2%) |
| Jun 2020 | - | -93.79%(+1.1%) |
| Mar 2020 | - | -92.79%(-6.5%) |
| Dec 2019 | -139.81%(+117.3%) | -99.23%(+28.2%) |
| Sep 2019 | - | -77.43%(-6.1%) |
| Jun 2019 | - | -82.50%(-16.5%) |
| Mar 2019 | - | -98.83%(+5.9%) |
| Dec 2018 | -64.34%(-85.6%) | -93.36%(-67.4%) |
| Sep 2018 | - | -286.16%(+3.3%) |
| Jun 2018 | - | -277.00%(-4.0%) |
| Mar 2018 | - | -288.63%(-64.5%) |
| Dec 2017 | -446.07%(+123.2%) | -814.13%(+50.6%) |
| Sep 2017 | - | -540.68%(-30.1%) |
| Jun 2017 | - | -773.77%(-67.0%) |
| Mar 2017 | - | -2346.78%(+78.6%) |
| Dec 2016 | -199.82%(-254.6%) | -1314.00%(-327.2%) |
| Sep 2016 | - | 578.25%(+274.7%) |
| Jun 2016 | - | 154.32%(+9.1%) |
| Mar 2016 | - | 141.46%(+1.0%) |
| Dec 2015 | 129.29% | 140.01%(-1.0%) |
| Sep 2015 | - | 141.39%(-33.2%) |
| Jun 2015 | - | 211.63%(-43.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | 373.93%(-51.2%) |
| Dec 2014 | 314.90%(-177.5%) | 766.51%(-125.3%) |
| Sep 2014 | - | -3030.74%(+233.9%) |
| Jun 2014 | - | -907.56%(+80.6%) |
| Mar 2014 | - | -502.45%(+26.8%) |
| Dec 2013 | -406.43%(+66.3%) | -396.31%(+13.1%) |
| Sep 2013 | - | -350.46%(+21.9%) |
| Jun 2013 | - | -287.39%(+12.0%) |
| Mar 2013 | - | -256.62%(+21.3%) |
| Dec 2012 | -244.36%(+167.8%) | -211.59%(+36.8%) |
| Sep 2012 | - | -154.66%(+14.3%) |
| Jun 2012 | - | -135.31%(+22.0%) |
| Mar 2012 | - | -110.89%(+16.2%) |
| Dec 2011 | -91.24%(+2.8%) | -95.47%(+3.7%) |
| Sep 2011 | - | -92.07%(+14.3%) |
| Jun 2011 | - | -80.53%(-4.9%) |
| Mar 2011 | - | -84.69%(+1.5%) |
| Dec 2010 | -88.79%(-30.2%) | -83.41%(+4.9%) |
| Sep 2010 | - | -79.51%(-15.7%) |
| Jun 2010 | - | -94.34%(-34.6%) |
| Mar 2010 | - | -144.29%(+19.4%) |
| Dec 2009 | -127.27%(+135.0%) | -120.87%(+43.3%) |
| Sep 2009 | - | -84.32%(+7.8%) |
| Jun 2009 | - | -78.19%(+4.5%) |
| Mar 2009 | - | -74.83%(+39.6%) |
| Dec 2008 | -54.16%(-45.2%) | -53.60%(-5.4%) |
| Sep 2008 | - | -56.65%(+20.4%) |
| Jun 2008 | - | -47.06%(-10.3%) |
| Mar 2008 | - | -52.46%(-13.6%) |
| Dec 2007 | -98.91%(-26.3%) | -60.72%(-0.2%) |
| Sep 2007 | - | -60.85%(-19.2%) |
| Jun 2007 | - | -75.29%(+46.1%) |
| Mar 2007 | - | -51.53%(-65.5%) |
| Dec 2006 | -134.18%(+222.5%) | -149.47%(+12.9%) |
| Sep 2006 | - | -132.40%(+36.9%) |
| Jun 2006 | - | -96.68%(+42.7%) |
| Mar 2006 | - | -67.75%(+66.6%) |
| Dec 2005 | -41.61%(-168.9%) | -40.66% |
| Dec 2004 | 60.37% | - |
FAQ
- What is DiaMedica Therapeutics annual return on equity?
- What is the all time high annual ROE for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual ROE year-on-year change?
- What is DiaMedica Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly ROE year-on-year change?
What is DiaMedica Therapeutics annual return on equity?
The current annual ROE of DMAC is -37.96%
What is the all time high annual ROE for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual return on equity is 314.90%
What is DiaMedica Therapeutics annual ROE year-on-year change?
Over the past year, DMAC annual return on equity has changed by +5.01% (+11.66%)
What is DiaMedica Therapeutics quarterly return on equity?
The current quarterly ROE of DMAC is -43.68%
What is the all time high quarterly ROE for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly return on equity is 766.51%
What is DiaMedica Therapeutics quarterly ROE year-on-year change?
Over the past year, DMAC quarterly return on equity has changed by -2.42% (-5.87%)